Tekla Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-72,225	Closed	-$1.15M	–	178
2022 Q4	$1.15M	Hold	72,225	–	–	0.04%	133
2022 Q3	$1.18M	Hold	72,225	–	–	0.05%	129
2022 Q2	$1.02M	Hold	72,225	–	–	0.04%	133
2022 Q1	$1.75M	Hold	72,225	–	–	0.06%	129
2021 Q4	$1.69M	Buy	+72,225	New	+$1.69M	0.05%	130
2021 Q3	–	Sell	-331,789	Closed	-$8.09M	–	173
2021 Q2	$8.09M	Hold	331,789	–	–	0.26%	96
2021 Q1	$8.56M	Hold	331,789	–	–	0.29%	90
2020 Q4	$17.7M	Buy	331,789 +81,046	+32%	+$4.33M	0.62%	45
2020 Q3	$10.3M	Hold	250,743	–	–	0.39%	60
2020 Q2	$12.2M	Buy	250,743 +29,144	+13%	+$1.41M	0.46%	47
2020 Q1	$9.36M	Buy	221,599 +3,316	+2%	+$140K	0.42%	45
2019 Q4	$9.34M	Buy	218,283 +58,136	+36%	+$2.49M	0.35%	66
2019 Q3	$5.76M	Hold	160,147	–	–	0.25%	76
2019 Q2	$4.28M	Buy	160,147 +55,433	+53%	+$1.48M	0.17%	97
2019 Q1	$2.81M	Buy	+104,714	New	+$2.81M	0.11%	119
2018 Q4	–	Sell	-93,689	Closed	-$1.95M	–	204
2018 Q3	$1.95M	Hold	93,689	–	–	0.07%	157
2018 Q2	$1.43M	Hold	93,689	–	–	0.05%	150
2018 Q1	$2.11M	Sell	93,689 -152,196	-62%	-$3.42M	0.08%	133
2017 Q4	$7.4M	Buy	+245,885	New	+$7.4M	0.29%	68
2017 Q1	–	Sell	-111,800	Closed	-$3.22M	–	140
2016 Q4	$3.22M	Hold	111,800	–	–	0.14%	87
2016 Q3	$3.56M	Sell	111,800 -251,785	-69%	-$8.01M	0.14%	98
2016 Q2	$11.8M	Sell	363,585 -351,714	-49%	-$11.4M	0.48%	53
2016 Q1	$20M	Buy	715,299 +77,799	+12%	+$2.18M	0.85%	30
2015 Q4	$22.7M	Buy	637,500 +75,000	+13%	+$2.67M	0.82%	24
2015 Q3	$18.6M	Buy	562,500 +192,500	+52%	+$6.37M	0.67%	33
2015 Q2	$15.5M	Buy	+370,000	New	+$15.5M	0.56%	38